PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
Clinical trial NCT00948090 · COMPLETED
Trial details
- NCT number
- NCT00948090
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.